Advanced search
Publication Cover
Epigenetics Volume 7, 2012 - Issue 11
Submit an article Journal homepage
721
Views
62
CrossRef citations to date
0
Altmetric
Research Paper

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Kim Andresen Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway; Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
,
Kirsten Boberg Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Section of Gastroenterology; Department of Transplantation Medicine; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
,
Hege Vedeld Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
,
Hilde Honne Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
,
Merete Hektoen Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
,
Chrisopher Wadsworth Hepatology and Gastroenterology Section; Division of Diabetes, Endocrinology and Metabolism; Department of Medicine; Imperial College London; London, UK
,
Ole Clausen Department of Pathology; Division of Diagnostics and Intervention; Oslo University Hospital; Oslo, Norway
,
Tom Karlsen Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Section of Gastroenterology; Department of Transplantation Medicine; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
,
Aksel Foss Section for Transplantation Surgery; Department of Transplantation Medicine; Division of Cancer Medicine, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Institute of Clinical Medicine; University of Oslo; Oslo, Norway
,
Øystein Mathisen Section for Hepatopancreatic and Biliary Surgery; Department of Gastrointestinal Surgery; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
,
Erik Schrumpf Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Section of Gastroenterology; Department of Transplantation Medicine; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Institute of Clinical Medicine; University of Oslo; Oslo, Norway
,
Ragnhild Lothe Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
&
Guro E. Lind Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, NorwayCorrespondence[email protected]
 show all
Pages 1249-1257 | Received 25 Jul 2012, Accepted 12 Sep 2012, Published online: 14 Sep 2012

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Margherita Rimini, Marco Puzzoni, Federica Pedica, Nicola Silvestris, Lorenzo Fornaro, Giuseppe Aprile, Eleonora Loi, Oronzo Brunetti, Caterina Vivaldi, Francesca Simionato, Patrizia Zavattari, Mario Scartozzi, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu & Andrea Casadei-Gardini. (2021) Cholangiocarcinoma: new perspectives for new horizons. Expert Review of Gastroenterology & Hepatology 15:12, pages 1367-1383.
Read now
Ranu S Sinniah, Mark S Shapses, Mohammad Umar Ahmed, Hani Babiker & Sreenivasa R. Chandana. (2021) Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1. Expert Opinion on Investigational Drugs 30:10, pages 1047-1056.
Read now
Antonio Cigliano, Xin Chen & Diego F. Calvisi. (2021) Current challenges to underpinning the genetic basis for cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 15:5, pages 511-526.
Read now
Kitti Intuyod, Napat Armartmuntree, Apinya Jusakul, Chadamas Sakonsinsiri, Raynoo Thanan & Somchai Pinlaor. (2019) Current omics-based biomarkers for cholangiocarcinoma. Expert Review of Molecular Diagnostics 19:11, pages 997-1005.
Read now
Barbara Kinga Barták, Alexandra Kalmár, Bálint Péterfia, Árpád V. Patai, Orsolya Galamb, Gábor Valcz, Sándor Spisák, Barnabás Wichmann, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz & Béla Molnár. (2017) Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. Epigenetics 12:9, pages 751-763.
Read now
Sebastian Meller, Lisa Zipfel, Heidrun Gevensleben, Jörn Dietrich, Jörg Ellinger, Michael Majores, Johannes Stein, Verena Sailer, Maria Jung, Glen Kristiansen & Dimo Dietrich. (2016) CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients. Epigenetics 11:12, pages 871-880.
Read now
Richard A. Burkhart, Daniel A. Laheru, Joseph M. Herman & Timothy M. Pawlik. (2016) Multidisciplinary management and the future of treatment in cholangiocarcinoma. Expert Opinion on Orphan Drugs 4:3, pages 255-267.
Read now
Erik Schrumpf, Kirsten Muri Boberg & Tom H. Karlsen. (2015) Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 50:6, pages 781-796.
Read now
Hege Marie Vedeld, Rolf I Skotheim, Ragnhild A Lothe & Guro E Lind. (2014) The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer. Epigenetics 9:3, pages 346-350.
Read now
Paul L Severson, Erik J Tokar, Lukas Vrba, Michael P Waalkes & Bernard W Futscher. (2013) Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation. Epigenetics 8:10, pages 1080-1088.
Read now
James RA Skipworth, John F Timms & Stephen P Pereira. (2013) Novel diagnostic and prognostic biomarkers in biliary tract cancer. Expert Opinion on Medical Diagnostics 7:5, pages 487-499.
Read now

Articles from other publishers (51)

Landon L. Moore & Courtney W. Houchen. (2023) Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells. International Journal of Molecular Sciences 24:22, pages 16407.
Crossref
Baiyin Zhong, Qicheng Liao, Xin Wang, Xiaonong Wang & Jianhong Zhang. (2023) The roles of epigenetic regulation in cholangiocarcinogenesis. Biomedicine & Pharmacotherapy 166, pages 115290.
Crossref
Anna Olechnowicz, Urszula Oleksiewicz & Marta Machnik. (2023) KRAB-ZFPs and cancer stem cells identity. Genes & Diseases 10:5, pages 1820-1832.
Crossref
Yu Wang, Yuhao Luo, Shaozhi Fu, Lijia He, Guangrui Pan, Dongmei Fan, Qinglian Wen & Yu Fan. (2023) Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer. Frontiers in Endocrinology 14.
Crossref
Bin Li, Baoqing Ren, Gang Ma, Fenglin Cai, Pengliang Wang, Yi Zeng, Yong Liu, Li Zhang, Yang Yang, Han Liang, Rupeng Zhang & Jingyu Deng. (2023) Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cells. Clinical Epigenetics 15:1.
Crossref
Minwook Kim, Evan Delgado & Sungjin Ko. (2023) DNA methylation in cell plasticity and malignant transformation in liver diseases. Pharmacology & Therapeutics 241, pages 108334.
Crossref
Shun He, Fanxin Zeng, Huihui Yin, Pei Wang, Yinlei Bai, Qianqian Song, Jiangtao Chu, Zhen Huang, Yumeng Liu, Hong Liu, Qichen Chen, Li Liu, Jun Zhou, Hanjie Hu, Xingchen Li, Tengyan Li, Guiqi Wang, Jianqiang Cai, Yuchen Jiao & Hong Zhao. (2023) Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples. eClinicalMedicine 55, pages 101736.
Crossref
Heidi Dietrichson Pharo, Marine Jeanmougin, Eirill Ager-Wick, Hege Marie Vedeld, Anne Klara Sørbø, Christina Dahl, Louise Katrine Larsen, Hilde Honne, Sara Brandt-Winge, May-Britt Five, Sara Monteiro-Reis, Rui Henrique, Carmen Jeronimo, Kenneth Steven, Rolf Wahlqvist, Per Guldberg & Guro Elisabeth Lind. (2022) BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients. Clinical Epigenetics 14:1.
Crossref
Qin Lu, Hailan Feng, Hong Chen, Nathaniel Weygant, Jian Du, Zixing Yan & Zhiyun Cao. (2022) Role of DCLK1 in oncogenic signaling (Review). International Journal of Oncology 61:5.
Crossref
Svetlana V. Chulkova, Vitaly I. Loginov, Danil V. Podluzhny, Angelina V. Egorova, Dmitry G. Semichev, Irina A. Gladilina & Nikolai E. Kudashkin. (2022) The role of molecular genetic factors in the development of cholangiocellular cancer: A review. Journal of Modern Oncology 24:2, pages 164-168.
Crossref
Albert J. Czaja. (2022) Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Frontiers in Immunology 13.
Crossref
Eleonora Loi, Cesare Zavattari, Alessandro Tommasi, Loredana Moi, Matteo Canale, Agnese Po, Claudia Sabato, Ana Florencia Vega-Benedetti, Pina Ziranu, Marco Puzzoni, Eleonora Lai, Luca Faloppi, María Rullán, Juan Carrascosa, Irene Amat, Jesús M. Urman, Maria Arechederra, Carmen Berasain, Elisabetta Ferretti, Andrea Casadei-Gardini, Matías A. Avila, Sergio Alonso, Mario Scartozzi & Patrizia Zavattari. (2022) HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples. British Journal of Cancer 126:12, pages 1783-1794.
Crossref
S.V. Chulkova, V.I. Loginov, D.V. Podluzhnyi, A.V. Egorova, A.Yu. Syskova, D.G. Semichev, I.A. Gladilina & N.E. Kudashkin. (2022) The role of molecular genetic factors in the development of cholangiocellular carcinoma. Arkhiv patologii 84:3, pages 76.
Crossref
Hege Marie Vedeld, Marit M. Grimsrud, Kim Andresen, Heidi D. Pharo, Erik von Seth, Tom H. Karlsen, Hilde Honne, Vemund Paulsen, Martti A. Färkkilä, Annika Bergquist, Marine Jeanmougin, Lars Aabakken, Kirsten M. Boberg, Trine Folseraas & Guro E. Lind. (2021) Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile. Hepatology 75:1, pages 59-73.
Crossref
Ju Dong Yang, Hassan Ghoz, Mohammed M. Aboelsoud, William R. Taylor, Tracy C. Yab, Calise K. Berger, Xiaoming Cao, Patrick H. Foote, Nasra H. Giama, Emily G. Barr Fritcher, Douglas W. Mahoney, Catherine D. Moser, Thomas C. Smyrk, Benjamin R. Kipp, Gregory J. Gores, Lewis R. Roberts & John B. Kisiel. (2021) DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma. Hepatology Communications 5:8, pages 1448-1459.
Crossref
Eline J. C. A. Kamp, Winand N. M. Dinjens, Michail Doukas, Marco J. Bruno, Pieter Jan F. de Jonge, Maikel P. Peppelenbosch & Annemarie C. de Vries. (2021) Optimal tissue sampling during ERCP and emerging molecular techniques for the differentiation of benign and malignant biliary strictures. Therapeutic Advances in Gastroenterology 14, pages 175628482110020.
Crossref
Giovanni Brandi & Simona Tavolari. 2021. Diagnosis and Management of Cholangiocarcinoma. Diagnosis and Management of Cholangiocarcinoma 471 494 .
Lorenzo Nevi, Sabina Di Matteo, Guido Carpino, Ilaria Grazia Zizzari, Samira Safarikia, Valeria Ambrosino, Daniele Costantini, Diletta Overi, Antonella Giancotti, Marco Monti, Daniela Bosco, Valerio De Peppo, Andrea Oddi, Agostino Maria De Rose, Fabio Melandro, Maria Consiglia Bragazzi, Jessica Faccioli, Sara Massironi, Gian Luca Grazi, Pierluigi Benedetti Panici, Paquale Bartomeo Berloco, Felice Giuliante, Vincenzo Cardinale, Pietro Invernizzi, Giuseppina Caretti, Eugenio Gaudio & Domenico Alvaro. (2021) DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma. Hepatology 73:1, pages 144-159.
Crossref
Hege Marie Vedeld, Trine Folseraas & Guro Elisabeth Lind. (2020) Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers. JHEP Reports 2:5, pages 100143.
Crossref
Liangliang Xu, Peng Wang, Xinfu Feng, Jianwei Tang, Lian Li, Xiaobo Zheng, Jinfu Zhang, Yitao Hu, Tian Lan, Kefei Yuan, Yanfang Zhang, Shengsheng Ren, Xiangyong Hao, Ming Zhang & Mingqing Xu. (2019) SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma. Clinical Science 133:20, pages 2085-2105.
Crossref
Lorenza Rimassa, Nicola Personeni, Alessio Aghemo & Ana Lleo. (2019) The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine. Journal of Autoimmunity 100, pages 17-26.
Crossref
Albert J. Czaja. 2019. Clinical Epidemiology of Chronic Liver Diseases. Clinical Epidemiology of Chronic Liver Diseases 251 305 .
Keishi Yamashita, Kei Hosoda, Nobuyuki Nishizawa, Hiroshi Katoh & Masahiko Watanabe. (2018) Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment . Cancer Science 109:12, pages 3695-3706.
Crossref
Shuji Nakamoto, Yusuke Kumamoto, Kazuharu Igarashi, Yoshiki Fujiyama, Nobuyuki Nishizawa, Shigenori Ei, Hiroshi Tajima, Takashi Kaizu, Masahiko Watanabe & Keishi Yamashita. (2018) Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma. PLOS ONE 13:10, pages e0205864.
Crossref
Hege Marie Vedeld, Ajay Goel & Guro E. Lind. (2018) Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives. Seminars in Cancer Biology 51, pages 36-49.
Crossref
Gyem TsheringPalden Wangyel DorjiWanna ChaijaroenkulKesara Na-Bangchang. (2018) Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review. The American Journal of Tropical Medicine and Hygiene 98:6, pages 1788-1797.
Crossref
Yanjiao Ren, Xin Feng, Xin Xia, Yexian Zhang, Wenniu Zhang, Jing Su, Zhongyu Wang, Ying Xu & Fengfeng Zhou. (2018) Gender specificity improves the early-stage detection of clear cell renal cell carcinoma based on methylomic biomarkers. Biomarkers in Medicine 12:6, pages 607-618.
Crossref
Weiying Liu, Shixing Wang, Qi Sun, Zhen Yang, Min Liu & Hua Tang. (2018) Retracted: DCLK1 promotes epithelial‐mesenchymal transition via the PI3K/Akt/NF‐κB pathway in colorectal cancer . International Journal of Cancer 142:10, pages 2068-2079.
Crossref
Keita Kojima, Takatoshi Nakamura, Makoto Ohbu, Hiroshi Katoh, Yosuke Ooizumi, Kazuharu Igarashi, Satoru Ishii, Toshimichi Tanaka, Keigo Yokoi, Nobuyuki Nishizawa, Kazuko Yokota, Yoshimasa Kosaka, Takeo Sato, Masahiko Watanabe & Keishi Yamashita. (2018) Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer. PLOS ONE 13:5, pages e0194785.
Crossref
Cheng Xu, Jiamei Liu, Weifeng Yang, Yayun Shu, Zhipeng Wei, Weiwei Zheng, Xin Feng & Fengfeng Zhou. (2018) An OMIC biomarker detection algorithm TriVote and its application in methylomic biomarker detection. Epigenomics 10:4, pages 335-347.
Crossref
Albert J. Czaja. (2018) Epigenetic changes and their implications in autoimmune hepatitis. European Journal of Clinical Investigation 48:4, pages e12899.
Crossref
Colm J. O'Rourke, Patricia Munoz-Garrido, Esmeralda L. Aguayo & Jesper B. Andersen. (2018) Epigenome dysregulation in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:4, pages 1423-1434.
Crossref
Hege Marie Vedeld, Marianne Merok, Marine Jeanmougin, Stine A. Danielsen, Hilde Honne, Gro Kummeneje Presthus, Aud Svindland, Ole H. Sjo, Merete Hektoen, Mette Eknaes, Arild Nesbakken, Ragnhild A. Lothe & Guro E. Lind. (2017) CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers . International Journal of Cancer 141:5, pages 967-976.
Crossref
V. Branchi, P. Schaefer, A. Semaan, A. Kania, P. Lingohr, J. C. Kalff, N. Schäfer, G. Kristiansen, D. Dietrich & H. Matthaei. (2016) Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. Clinical Epigenetics 8:1.
Crossref
T. Powrózek, P. Krawczyk, M. Nicoś, B. Kuźnar-Kamińska, H. Batura-Gabryel & J. Milanowski. (2015) Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Clinical and Translational Oncology 18:4, pages 398-404.
Crossref
Fang Zhao & Bharati Bapat. 2016. Epigenetic Biomarkers and Diagnostics. Epigenetic Biomarkers and Diagnostics 155 173 .
Ivette A.G. Deckers, Leo J. Schouten, Leander Van Neste, Iris J.H. van Vlodrop, Patricia M.M.B. Soetekouw, Marcella M.L.L. Baldewijns, Jana Jeschke, Nita Ahuja, James G. Herman, Piet A. van den Brandt & Manon van Engeland. (2015) Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome . Clinical Cancer Research 21:15, pages 3492-3500.
Crossref
Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Hilde Honne, Peter Jebsen, Merete Hektoen, Christopher A. Wadsworth, Ole Petter Clausen, Knut E.A. Lundin, Vemund Paulsen, Aksel Foss, Øystein Mathisen, Lars Aabakken, Erik Schrumpf, Ragnhild A. Lothe & Guro E. Lind. (2015) Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology 61:5, pages 1651-1659.
Crossref
Sarinya Kongpetch, Apinya Jusakul, Choon Kiat Ong, Weng Khong Lim, Steven G. Rozen, Patrick Tan & Bin Tean Teh. (2015) Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. Best Practice & Research Clinical Gastroenterology 29:2, pages 233-244.
Crossref
Hege Marie Vedeld, Kim Andresen, Ina Andrassy Eilertsen, Arild Nesbakken, Raquel Seruca, Ivar P. Gladhaug, Espen Thiis‐Evensen, Torleiv O. Rognum, Kirsten Muri Boberg & Guro E. Lind. (2014) The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers . International Journal of Cancer 136:4, pages 844-853.
Crossref
Nathaniel Weygant, Dongfeng Qu, Randal May, Ryan M. Tierney, William L. Berry, Lichao Zhao, Shweta Agarwal, Parthasarathy Chandrakesan, Harisha R. Chinthalapally, Nicholas T. Murphy, James D. Li, Sripathi M. Sureban, Michael J. Schlosser, James J. Tomasek & Courtney W. Houchen. (2014) DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma. Oncotarget 6:4, pages 2193-2205.
Crossref
Nicole Bethge, Hilde Honne, Kim Andresen, Vera Hilden, Gunhild Trøen, Knut Liestøl, Harald Holte, Jan Delabie, Guro E. Lind & Erlend B. Smeland. (2014) A Gene Panel, Including LRP12, Is Frequently Hypermethylated in Major Types of B-Cell Lymphoma. PLoS ONE 9:9, pages e104249.
Crossref
Sripathi M. Sureban, Randal May, Nathaniel Weygant, Dongfeng Qu, Parthasarathy Chandrakesan, Eddie Bannerman-Menson, Naushad Ali, Panayotis Pantazis, Christoph B. Westphalen, Timothy C. Wang & Courtney W. Houchen. (2014) XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Letters 351:1, pages 151-161.
Crossref
Pengcheng Kang, Ming Wan, Peng Huang, Chunlong Li, Zhidong Wang, Xiangyu Zhong, Zhanliang Hu, Sheng Tai & Yunfu Cui. (2014) The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma. PLoS ONE 9:3, pages e90308.
Crossref
Mohammed ShakerKara M. PascarelliMatthew J. PlantingaMiles A. LoveAlexander J. LazarDavis R. IngramMargaret Von MehrenDina LevDavid KiplingDominique Broccoli. (2014) Differential Expression of Cysteine Dioxygenase 1 in Complex Karyotype Liposarcomas. Biomarkers in Cancer 6, pages BIC.S14683.
Crossref
Yang Yang, Yu-Chen Fan, Shuai Gao, Cheng-Yun Dou, Jian-Jun Zhang, Feng-Kai Sun & Kai Wang. (2014) Methylated Cysteine Dioxygenase-1 Gene Promoter in the Serum Is a Potential Biomarker for Hepatitis B Virus-Related Hepatocellular Carcinoma. The Tohoku Journal of Experimental Medicine 232:3, pages 187-194.
Crossref
Ross C. Smith. 2014. Biliary Tract and Gallbladder Cancer. Biliary Tract and Gallbladder Cancer 67 82 .
Chen Li, Weixing Shen, Sheng Shen & Zhilong Ai. (2013) Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinoma. Computational Biology and Chemistry 47, pages 192-197.
Crossref
Chiara Raggi & Pietro Invernizzi. (2013) Methylation and liver cancer. Clinics and Research in Hepatology and Gastroenterology 37:6, pages 564-571.
Crossref
Tom H. Karlsen & Kirsten Muri Boberg. (2013) Update on primary sclerosing cholangitis. Journal of Hepatology 59:3, pages 571-582.
Crossref
Sripathi M. Sureban, Dongfeng Qu & Courtney W. Houchen. 2013. Epigenetics and Cancer. Epigenetics and Cancer 115 128 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.